From the article: "Survivorship guidelines are advice from the American Cancer Society to help doctors, nurses, and other professionals take care of cancer survivors who have finished their cancer treatments. The survivorship guidelines presented here address issues that can occur in men after the treatment of prostate cancer."

This resource provides an action-oriented playbook to be adopted throughout the COVID-19 pandemic and aims to align NCCRT members, 80% pledged partners, and colorectal cancer screening advocates across the nation to work together to reignite our screening efforts appropriately, safely, and equally for all communities.

The COVID-19 pandemic has challenged efforts to address inadequate screening and inequities in colorectal cancer outcomes, hindering the progress toward our 80% in Every Community goals. In the early stages of the COVID-19 pandemic, leading agencies, such as the Centers for Medicare & Medicaid Services (CMS) and the American Cancer Society, made recommendations to delay all non-urgent procedures. Colonoscopies to detect colorectal cancer have been delayed or cancelled and patient fears about contracting COVID-19 have led to further reductions in screening. This drop has raised concern that COVID-19 related screening delays will lead to missed and advanced stage colorectal cancer diagnoses and to excess deaths from colorectal cancer. Moreover, this burden will likely not be evenly distributed as screening disparities may be exacerbated in communities and populations that are disadvantaged by both old and new challenges in the COVID-19 era.

The colorectal cancer fighting community stands prepared and well-positioned to respond to and overcome the difficult task ahead, and this document offers the latest (as of June 2020) data, research, and clinical guidelines available related to colorectal cancer screening and COVID-19. 

The objectives of this archived webinar from NCI are:

1. Describe factors that influence the selection and initiation of cancer treatment
2. Identify common side effects of treatment 
3. Discuss the challenges faced by cancer survivors
4. Identify key National Cancer Institute (NCI) treatment and survivorship resources
 

Instructor Bio:
Annette Galassi, RN, MA, is a Public Health Advisor in the National Cancer Institute's (NCI) Office of Communication and Education (OCE). Her career began as a staff nurse in medical oncology at Memorial Sloan-Kettering Cancer Center where she was also a Clinical Nurse Specialist.  Ms. Galassi moved to Washington, DC in 1986 and was a Clinical Nurse Specialist at the Clinical Center, National Institutes of Health.  During that time she completed a post-Master’s certificate as an Adult Nurse Practitioner at the University of Maryland.  In 1993, Ms Galassi joined the faculty of Georgetown University's Lombardi Cancer Center, where she was their first Oncology Nurse Practitioner.  Ms. Galassi returned to government service in 1998, joining the National Cancer Institute’s Office of Communications where she oversaw the training program for the Cancer Information Service. Ms. Galassi received her Bachelor of Science degree in nursing from the State University of New York at Albany and her Master of Arts degree in advanced nursing science from New York University.  She has published numerous articles and chapters in the field of oncology nursing.  Her awards include the NIH Merit Award and Georgetown University’s Nurse of the Year.  Ms. Galassi is a member of the Oncology Nursing Society, the American Society of Clinical Oncology, the International Society of Nurses in Cancer Care and the International Association of Clinical Research Nurses.

"Decision Making at the Point of Care: Voices of Oncology Providers" was developed as part of CancerCare's Patient Values Initiative (PVI), a multi-pronged effort aimed at reframing the national healthcare policy framework to ensure that patient engagement in treatment decision-making becomes the true standard of care. CancerCare's second PVI report highlights provider perspectives on the importance and utility of learning about their patients' lifestyles and priorities.